Mylan's pretax EpiPen profits 60 percent higher than congressional testimony. Via @SarahKarlin: http://politico.pro/2cylOBW | Photo: APpic.twitter.com/i0eeLTw8ik
9:16 AM - 26 Sep 2016
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.